 |
|
New Users of Antipsychotic Medications Among Children Enrolled in TennCare
William O. Cooper, MD, MPH;
Gerald B. Hickson, MD;
Catherine Fuchs, MD;
Patrick G. Arbogast, PhD;
Wayne A. Ray, PhD
Arch Pediatr Adolesc Med. 2004;158:753-759.
Background The use of antipsychotic medications in children and adolescents for indications other than psychosis or Tourette syndrome is controversial. Newer atypical antipsychotics with profiles of adverse effects that differ from those of traditional antipsychotics may lead providers to prescribe antipsychotics more frequently than in the past for behavioral indications not strongly supported by clinical study.
Objective To identify population-based new use of antipsychotics among patients aged 2 to 18 years.
Design Retrospective cohort study, January 1, 1996, through December 31, 2001.
Setting Tennessee's managed care program for Medicaid enrollees and the uninsured (TennCare).
Main Outcome Measures New use of antipsychotic medications and indications for use by the child's diagnosis, adjusted for age, sex, race, county of residence, enrollment category, and income.
Results The proportion of TennCare children who were new users of antipsychotics, adjusted for demographic characteristics, nearly doubled from 23/10 000 in 1996 to 45/10 000 in 2001 (adjusted incidence rate ratio, 1.98; 95% confidence interval, 1.82-2.16). In 1996, 6.8% of new users received an atypical antipsychotic; by 2001, this had increased to 95.9%. New use for attention-deficit/hyperactivity disorder and affective disorders increased 2.5-fold. New use of antipsychotics for schizophrenia, acute psychotic reaction, Tourette syndrome, and mental retardation or autism remained relatively constant. Secular trends of increasing use were most pronounced for those aged 6 to 12 years (93% increase) and 13 to 18 years (116% increase), although use among preschool children increased 61% during the study period.
Conclusion The proportion of TennCare children who became new users of antipsychotics nearly doubled from 1996 to 2001, with a substantial increase in use of antipsychotics for attention-deficit/hyperactivity disorder, conduct disorder, and affective disorders.
From the Division of General Pediatrics, Department of Pediatrics (Drs Cooper and Hickson), the Division of Child and Adolescent Psychiatry, Department of Psychiatry (Dr Fuchs), and the Divisions of Biostatistics (Dr Arbogast) and Pharmacoepidemiology (Dr Ray), Department of Preventive Medicine, Vanderbilt University, Nashville, Tenn.
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
RELATED ARTICLE
Prescribing More Psychotropic Medications for Children: What Does the Increase Mean?
Peter Conrad
Arch Pediatr Adolesc Med. 2004;158(8):829-830.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Antipsychotic Medication Use Among Children and Risk of Diabetes Mellitus
Andrade et al.
Pediatrics 2011;128:1135-1141.
ABSTRACT
| FULL TEXT
Suicidal Behavior Differs Among Early and Late Adolescents Treated With Antidepressant Agents
Hysinger et al.
Pediatrics 2011;128:447-454.
ABSTRACT
| FULL TEXT
Multiple Psychiatric Diagnoses Common in Privately Insured Children on Atypical Antipsychotics
Halloran et al.
CLIN PEDIATR 2010;49:485-490.
ABSTRACT
Broadened Use Of Atypical Antipsychotics: Safety, Effectiveness, And Policy Challenges
Crystal et al.
Health Aff (Millwood) 2009;28:w770-w781.
ABSTRACT
| FULL TEXT
Changing Utilization of Pro Re Nata ('As Needed') Sedation in a Child and Adolescent Psychiatric Inpatient Unit
Dean et al.
Aust N Z J Psychiatry 2009;43:360-365.
ABSTRACT
| FULL TEXT
Metabolic and Cardiovascular Adverse Events Associated With Antipsychotic Treatment in Children and Adolescents
McIntyre and Jerrell
Arch Pediatr Adolesc Med 2008;162:929-935.
ABSTRACT
| FULL TEXT
Side Effects of Second-Generation Antipsychotics: The Experiences, Views and Monitoring Practices of Australian Child Psychiatrists
Walter et al.
Australas Psychiatry 2008;16:253-262.
ABSTRACT
| FULL TEXT
Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United Kingdom
Rani et al.
Pediatrics 2008;121:1002-1009.
ABSTRACT
| FULL TEXT
Psychotropic Medication Patterns Among Youth in Foster Care
Zito et al.
Pediatrics 2008;121:e157-e163.
ABSTRACT
| FULL TEXT
Effect of Regulatory Warnings on Antidepressant Prescribing for Children and Adolescents
Kurian et al.
Arch Pediatr Adolesc Med 2007;161:690-696.
ABSTRACT
| FULL TEXT
National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.
Olfson et al.
Arch Gen Psychiatry 2006;63:679-685.
ABSTRACT
| FULL TEXT
Diagnoses and Antipsychotic Treatment Among Youths in a Public Mental Health System
Patel et al.
The Annals of Pharmacotherapy 2006;40:205-211.
ABSTRACT
| FULL TEXT
Prevalence of Atypical Antipsychotic Drug Use Among Commercially Insured Youths in the United States
Curtis et al.
Arch Pediatr Adolesc Med 2005;159:362-366.
ABSTRACT
| FULL TEXT
Scientifically Unsupported and Supported Interventions for Childhood Psychopathology: A Summary
Lilienfeld
Pediatrics 2005;115:761-764.
ABSTRACT
| FULL TEXT
Bush launches controversial mental health plan
Lenzer
BMJ 2004;329:367-367.
FULL TEXT
The Rewards of Reducing Risk
Brent
Arch Pediatr Adolesc Med 2004;158:824-825.
FULL TEXT
Prescribing More Psychotropic Medications for Children: What Does the Increase Mean?
Conrad
Arch Pediatr Adolesc Med 2004;158:829-830.
FULL TEXT
|
